Picture of CureVac NV logo

CVAC CureVac NV Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Annual cashflow statement for CureVac NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-71.1-100-130-412-249
Depreciation
Deferred Taxes
Non-Cash Items-5.8920.440.2-35067.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.871-14.460215.4-129
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-74.1-87522-733-286
Capital Expenditures-14.7-12.2-47.4-128-93.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items10.540.42.080-0.277
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-4.2628.2-45.3-128-93.5
Financing Cash Flow Items66.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.1126882034563.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-78.39.31,292-511-316